In the New York State Courts
Southern District of New York Bans Martin Shkreli from Pharmaceutical Industry for Life and Orders the Disgorgement of $64 Million in Ill-Gotten Profits Fed. Trade Comm’n v. Shkreli, No. 20 Civ. 706, 2022 WL 135026 (S.D.N.Y. Jan. 14, 2022). Martin Shkreli achieved infamy in 2015. After acquiring the rights to Daraprim – a life-saving anti-parasitic … Continued
